Physician profile
Erin E Pope
NPI 1649275769
$1,650.73
in general payments reported to CMS, 2019-2025
19 companies · $796 in 2025
The $796 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $143 · 2023: $187 · 2024: $327 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $276.15 | 2024-2025 | |
| Ucb, INC. | $206.81 | 2024-2025 | Briviact, Nayzilam |
| Abbvie INC. | $189.08 | 2022-2025 | |
| Amgen INC. | $151.81 | 2021-2023 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $107.08 | 2021-2025 | |
| Radius Health, INC. | $100.52 | 2021-2023 | Tymlos |
| Lundbeck LLC | $82.71 | 2021-2025 | Vyepti |
| Neurelis, INC. | $71.75 | 2024-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $63.44 | 2021-2023 | Strensiq |
| Catalyst Pharmaceuticals, INC. | $57.49 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $54.61 | 2025 | Austedo Xr |
| Genentech USA, INC. | $48.81 | 2024 | Ocrevus, Ocrevus Zunovo |
| Sk Life Science, INC. | $44.65 | 2025 | |
| Avanir Pharmaceuticals, INC. | $43.44 | 2021 | |
| Neurocrine Biosciences, INC. | $36.83 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $34.73 | 2022 | |
| Tg Therapeutics, INC. | $32.91 | 2025 | |
| Axsome Therapeutics, INC. | $24.68 | 2025 | Symbravo |
| Medtronic, INC. | $23.23 | 2024 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.